matthiasdrosten.bsky.social
Principal Investigator at Centro de Investigación del Cáncer (CIC), Salamanca, Spain | RAS signaling and lung cancer
👤 Joined on 18 November 2024
Followers
Following
Total Posts
@matthiasdrosten.bsky.socialEACR Board members and other key opinion leaders author regular EACR Viewpoint articles in our affiliated journal, @moloncology.bsky.social 'The rapidly growing landscape of RAS inhibitors: from selective allele blockade to broad inhibition strategies': febs.onlinelibrary.wiley.com/doi/10.1002/...
Show PostThe repressor #Capicua is a barrier to #LungTumor development driven by Kras/Trp53 mutations 👉 doi.org/10.1038/s443... By I. Ballesteros-González, @matthiasdrosten.bsky.social & colleagues @ciberisciii.bsky.social @ciccancer.bsky.social
Show Post🧵1/17 📣Thrilled to share our latest study just out in Cancer Discovery! ➡️ aacrjournals.org/cancerdiscov...
Show Post📢 Early Bird registration for Targeting RAS 2025 closes in just one month — on August 31st! 🧬 Join now the international RAS community in Salamanca and benefit from discounted access. 🔗 Register now: https://targetingras.com/registration #TargetingRAS2025 #EarlyBird #CancerResearch #RASBiology
Show PostExcited to share that our #canSERV proposal has been approved! FerrandizLab will explore endomembrane remodelling in cancer cells using advanced electron microscopy at @embl.org , with support from @eurobioimaging.bsky.social Let the ultrastructure journey begin! 🔬✨
Show Post